Shareholding disclosure

Kuros Biosciences AG

Collectively declared rate

25.63%

Threshold

Crossed upwards

Timeline

Published

28.10.2020

Transaction

26.10.2020

Voting rights breakdown

Voting rights acquired25.63%
Voting rights sold0%
Below threshold0%

Declared beneficial owners · 4

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TBKAQ00040

Beneficial owner

Frank-Jan van der Velden

Declared address

Frank-Jan van der Velden, Echteld

Incubation B.V., holding 1'112'101 shares (3.39% of the Company's voting rights), is controlled on a 50:50 basis by (i) Dagomar B.V., Echteld, the Netherlands, a company controlled by Mr. Frank-Jan van der Velden, Echteld, The Netherlands and (ii) Dr. C.A. van Blitterswijk Holding B.V., Ruigahuizen, the Netherlands, a company controlled by Mr. Clemens von Bitterswijk, Ruigahuizen, The Netherlands. Aldabra B.V., Amersfoort, The Netherlands, holding 1'160'106 shares (3.54% of the Company's voting rights), is controlled by Mr. Joost de Bruijn, Amersfoort, The Netherlands. Optiverder B.V., holding 5'790'940 shares (17.65% of the Company's voting rights) is controlled by Mr. Chris Oomen, Delft, The Netherlands

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open